| Literature DB >> 30915217 |
Shuangbo Liu1, Christopher Parr1, Hannah Zhang1, Basem Elbarouni1, Ashish Shah1, Malek Kass1, Amir Ravandi1.
Abstract
OBJECTIVES: To determine patient outcomes in GuideLiner facilitated percutaneous coronary intervention stratified by the SYNTAX score.Entities:
Keywords: Acute myocardial infarction; catheter-based coronary interventions; complex coronary intervention
Year: 2019 PMID: 30915217 PMCID: PMC6429640 DOI: 10.1177/2048004019835449
Source DB: PubMed Journal: JRSM Cardiovasc Dis ISSN: 2048-0040
Study characteristics of all patients.
| Variable | n = 540 |
|---|---|
| Age (years) | 70 (61–78) |
| Male gender | 415, 77% |
| BMI (kg/m2) | 29 (26, 33) |
| Medical history | |
| Hypertension | 382, 71% |
| Dyslipidemia | 305, 56% |
| Stroke | 57, 11% |
| Diabetes | 196, 36% |
| Smoking | 94, 17% |
| PVD | 51, 9.4% |
| CKD | 73, 14% |
| CHF | 57, 11% |
| Prev MI | 242, 45% |
| Prev PCI | 192, 36% |
| Prev CABG | 110, 20% |
| Reason for angiography | |
| STEMI | 113, 21% |
| NSTEMI | 145, 27% |
| Elective | 194, 36% |
| Other | 88, 16% |
| At presentation | |
| VT/VF | 17, 4% |
| Cardiogenic shock | 57, 12% |
| Creatinine (µmol/L) | 91 (75, 130) |
| LVEDP, (mmHg) | 19 ± 8 |
| LVEF (%) | 51 ± 15 |
| Syntax (n = 430) | 21 ± 11 |
| Access | |
| Femoral | 250, 46% |
| Radial | 261, 48% |
| Both | 29, 5% |
| Fluoroscopy time (min) | 23 (16, 35) |
| Total contrast (mL) | 200 (155, 260) |
| GuideLiner used for | |
| Left main | 14, 3% |
| LAD | 109, 20% |
| Circumflex | 95, 18% |
| RCA | 282, 52% |
| Ramus | 1, 1% |
| LIMA | 4, 1% |
| SVG | 35, 7% |
Mean ± SD or Median ± IQR for continuous variables. Frequency, % for categorical variables. BMI: body mass index; CABG: coronary artery bypass grafting; CHF: congestive heart failure; CKD: chronic kidney disease; LAD: left anterior descending; LIMA: left internal mammary artery; LVEDP: left ventricular end diastolic pressure; LVEF: left ventricular ejection fraction; MI: myocardial infarction; NSTEMI: non-ST-segment myocardial infarction; PCI: percutaneous coronary intervention; PVD: peripheral vascular disease; RCA: right coronary artery; SS: syntax score; STEMI: ST-segment myocardial infarction; SVG: saphenous vein graft; TIMI: thrombolysis in myocardial infarction; VT: ventricular tachycardia; VF: ventricular fibrillation.
Procedural characteristics and outcomes of all patients.
| Variable | All patientsn = 540 |
|---|---|
| Indication | |
| Increased support | 443, 82% |
| Non-coaxial guide | 30, 6% |
| CTO | 51, 9% |
| Other | 15, 3% |
| Lesion length (mm) | 10 (5, 18) |
| Bifurcation or trifurcation | 77, 14% |
| CTO | 63, 12% |
| Proximal lesion | 207, 38% |
| Extreme tortuosity | 130, 24% |
| Severe calcification | 174, 32% |
| Thrombus | 61, 11% |
| Anomalous takeoff | 43, 8% |
| ACC/AHA lesion classification | |
| A | 71 (13%) |
| B | 214 (40%) |
| C | 255 (47%) |
| Successful delivery | 487, 91% |
| Final TIMI grade 3 | 491, 91% |
| Need for additional support | |
| None | 479, 89% |
| Device (IABP, Impella, ECMO) | 12, 2% |
| Vasopressors | 48, 9% |
| Cath complications | |
| None | 540, 100% |
| In-hospital mortality | 15 (2.7%) |
| 30 day mortality | 11 (2.1%) |
| 1 year mortality | 23 (4.5%) |
| 30 day repeat MI | 18 (3.4%) |
| 1 year repeat MI | 19 (3.7%) |
| In-hospital CABG | 10 (1.9%) |
| 30 day revascularization | 26 (5.0%) |
| 1 year revascularization | 74 (14%) |
| 30 day CHF | 12 (2.3%) |
| 1 year CHF | 14 (2.6%) |
Mean ± SD or Median ± IQR for continuous variables. Frequency, % for categorical variables. ACC: American College of Cardiology; AHA: American Heart Association; CABG: coronary artery bypass grafting; CHF: congestive heart failure; CTO: chronic total occlusion; ECMO: extracorporeal membrane oxygenation; IABP: intraortic balloon pump; MI: myocardial infarction; TIMI: thrombolysis in myocardial infarction.
Study characteristics stratified by SYNTAX score.
| Variable | SS ≤ 22n = 263 | SS = 23–32n = 103 | SS ≥ 33n = 62 | p-Value[ |
|---|---|---|---|---|
| Age (years) | 68 (60–75) | 68 (61–80) | 73 (62–83) | 0.005 |
| Male gender | 69 (26%) | 24 (23%) | 12 (19%) | 0.498 |
| BMI (kg/m2) | 29.7 (26.4–33.4) | 28.0 (25.3–32.4) | 27.2 (25.0–30.3) | 0.003 |
| Medical history | ||||
| Hypertension | 176, 67% | 76, 74% | 44, 71% | 0.28 |
| Dyslipidemia | 151, 57% | 54, 52% | 32, 52% | 0.96 |
| Stroke | 21, 8.0% | 10, 9.7% | 12, 19% | 0.004 |
| Diabetes | 84, 32% | 38, 37% | 26, 42% | 0.17 |
| Smoking | 59, 22% | 14, 14% | 13, 21% | 0.24 |
| PVD | 13, 5% | 12, 12% | 13, 21% | <0.001 |
| CKD | 23, 8.7% | 22, 21% | 11, 18% | <0.001 |
| CHF | 23, 8.7% | 8, 7.8% | 9, 15% | 0.20 |
| Prev MI | 108, 41% | 38, 37% | 19, 31% | 0.45 |
| Prev PCI | 106, 40% | 40, 39% | 7, 11% | <0.001 |
| Reason for angio | ||||
| STEMI | 54, 21% | 28, 27% | 26, 42% | 0.003 |
| NSTEMI | 81, 31% | 25, 24% | 16, 26% | |
| Elective | 106, 40% | 36, 35% | 17, 27% | |
| Other | 22, 8.4% | 14, 14% | 3, 5% | |
| At presentation | ||||
| VT/VF | 11, 5% | 1, 1% | 3, 6% | 0.25 |
| Cardiogenic shock | 19, 8% | 16, 18% | 13, 24% | <0.001 |
| Creatinine (µmol/L) | 86 (72–119) | 99 (73–205) | 103 (79–137) | 0.036 |
| LVEDP (mmHg) | 19 ± 8 | 19 ± 8 | 22 ± 9 | 0.01 |
| LVEF (%) | 55 ± 14 | 48 ± 16 | 48 ± 15 | <0.001 |
| Access | ||||
| Femoral | 81, 31% | 53, 52% | 31, 49% | 0.003 |
| Radial | 165, 63% | 44, 31% | 29, 46% | |
| Both | 16, 6% | 5, 5% | 3, 5% | |
| Fluoroscopy time (min) | 21 (14, 32) | 23 (18, 35) | 26 (21, 34) | 0.008 |
| Total contrast (mL) | 200 (150, 250) | 208 (160, 260) | 230 (160, 280) | 0.05 |
| GuideLiner used for | ||||
| Left main | 3, 1% | 2, 2% | 4, 6% | 0.05 |
| LAD | 44, 17% | 31, 30% | 17, 25% | |
| Circumflex | 42, 16% | 16, 15% | 15, 24% | |
| RCA | 172, 66% | 55, 52% | 28, 45% | |
| Ramus | 1, 0% | 1, 1% | 0 | |
| LIMA | 0 | 0 | 0 | |
| SVG | 0 | 0 | 0 |
Mean ± SD or Median ± IQR for continuous variables. Frequency, % for categorical variables. BMI: body mass index; CABG: coronary artery bypass grafting; CHF: congestive heart failure; CKD: chronic kidney disease; LAD: left anterior descending; LIMA: left internal mammary artery; LVEDP: left ventricular end diastolic pressure; LVEF: left ventricular ejection fraction; MI: myocardial infarction; NSTEMI: non-ST-segment myocardial infarction; PCI: percutaneous coronary intervention; PVD: peripheral vascular disease; RCA: right coronary artery; SS: syntax score; STEMI: ST-segment myocardial infarction; SVG: saphenous vein graft; TIMI: thrombolysis in myocardial infarction; VT: ventricular tachycardia; VF: ventricular fibrillation.
aComparing SS < 22, SS = 23–32 and SS >33 groups.
Procedural characteristics and outcomes of patients stratified by SYNTAX score.
| Variable | SS ≤ 22n = 263 | SS = 23–32n = 103 | SS ≥ 33n = 62 | p-Valuea |
|---|---|---|---|---|
| Indication | ||||
| Increased support | 184, 81% | 86, 83% | 53, 85% | 0.85 |
| Non-coaxial guide | 26, 9.8% | 6, 6% | 5, 8% | |
| CTO | 41, 16% | 10, 10% | 3, 5% | |
| Other | 10, 3.8% | 1, 1% | 1, 2% | |
| Lesion length (mm) | 8 (5–15) | 10 (6–20) | 14 (10–20) | <0.001 |
| Bifurcation or trifurcation | 31 (11.8%) | 20 (19.4%) | 15 (24.2%) | 0.023 |
| CTO | 35 (13.3%) | 15 (14.7%) | 3 (4.8%) | 0.138 |
| Proximal lesion | 95 (36.1%) | 45 (43.7%) | 30 (48.4%) | 0.132 |
| Extreme tortuosity | 66 (25.1%) | 30 (29.1%) | 17 (27.4%) | 0.720 |
| Severe calcification | 67 (25.5%) | 46 (44.7%) | 34 (54.8%) | <0.001 |
| Thrombus | 32 (12.2%) | 10 (9.7%) | 13 (21.0%) | 0.097 |
| Anomalous takeoff | 22 (8.4%) | 7 (6.8%) | 6 (9.7%) | 0.795 |
| ACC/AHA lesion classification | ||||
| A | 36 (14%) | 9 (9%) | 8 (13%) | 0.43 |
| B | 104 (39%) | 41 (39%) | 20 (32%) | |
| C | 123 (47%) | 53 (52%) | 34 (55%) | |
| Successful delivery | 239 (90.9%) | 91 (90.1%) | 56 (90.3%) | 0.971 |
| Final TIMI grade flow 3 | 251 (95.4%) | 89 (86.4%) | 49 (79.0%) | <0.001 |
| Need for additional support | ||||
| None | 239, 91% | 93, 90% | 49, 79% | 0.03 |
| Device (IABP, Impella, ECMO) | 2, 1% | 1, 1% | 4, 2% | |
| Vasopressors | 22, 8% | 9, 9% | 9, 14% | |
| Cath complications | ||||
| None | 262, 100% | 105, 100% | 63, 100% | – |
| In-hospital mortality | 4 (1.5%) | 3 (2.9%) | 5 (8.1%) | 0.025 |
| 30 day mortality | 5 (1.9%) | 4 (4.0%) | 2 (3.5%) | 0.408 |
| 1 year mortality | 9 (3.6%) | 7 (7.3%) | 1 (1.8%) | 0.237 |
| 30 day repeat MI | 8 (3.1%) | 4 (3.9%) | 2 (3.2%) | 0.925 |
| 1 year repeat MI | 9 (3.5%) | 2 (2.0%) | 4 (6.7%) | 0.353 |
| In-hospital CABG | 4 (1.5%) | 4 (3.9%) | 0 (0.0%) | 0.244 |
| 30 day revasculatization | 11 (4.3%) | 6 (5.9%) | 6 (9.8%) | 0.228 |
| 1 year revascularization | 33 (12.6%) | 8 (7.8%) | 15 (24.2%) | 0.010 |
| 30 day CHF | 3 (1.2%) | 1 (1.0%) | 1 (1.8%) | 0.820 |
| 1 year CHF | 3 (1.2%) | 3 (3.0%) | 3 (4.8%) | 0.116 |
Mean ± SD or Median ± IQR for continuous variables. Frequency, % for categorical variables. ACC: American College of Cardiology; AHA: American Heart Association; CABG: coronary artery bypass grafting; CHF: congestive heart failure; CTO: chronic total occlusion; ECMO: extracorporeal membrane oxygenation; IABP: intraortic balloon pump; MI: myocardial infarction; TIMI: thrombolysis in myocardial infarction.aComparing SS<22, SS = 23–32 and SS >33 groups.
Lesion and patient characteristics and outcomes stratified by clinical presentation.
| STEMIn=113 | NSTEMIn=145 | Electiven=194 | p-Value | |
|---|---|---|---|---|
| Cardiogenic shock | 47 (42%) | 7 (4.8%) | 3 (1.5%) | <0.0001 |
| Bifurcation/trifurcation | 14 (12%) | 18 (12%) | 26 (13%) | 0.95 |
| CTO | 2 (1.8%) | 5 (3.4%) | 53 (27%) | <0.0001 |
| Proximal | 48 (42%) | 60 (41%) | 75 (39%) | 0.78 |
| Tortuosity | 29 (26%) | 37 (26%) | 48 (25%) | 0.98 |
| Calcification | 34 (30%) | 49 (34%) | 69 (36%) | 0.62 |
| Anomalous | 8 (7%) | 14 (9.7%) | 16 (8.2%) | 0.56 |
| Type A | 16 (14%) | 19 (13%) | 23 (12%) | 0.35 |
| Type B | 55 (49%) | 66 (46%) | 49 (25%) | <0.0001 |
| Type C | 42 (37%) | 60 (41%) | 122 (63%) | <0.0001 |
| Indication for GuideLiner | ||||
| Increase support | 100 (88%) | 131 (90%) | 132 (68%) | <0.0001 |
| Not coaxial | 7 (6.2%) | 9 (6.2%) | 11 (5.7%) | |
| CTO | 1 (0.9%) | 1 (0.7%) | 46 (24%) | |
| Other | 4 (3.5%) | 4 (2.8%) | 5 (2.6%) | |
| Final TIMI 3 | 93 (82%) | 115 (79%) | 173 (89%) | 0.038 |
| Successful delivery | 104 (92%) | 127 (88%) | 176 (91%) | 0.45 |
| In-hospital mortality | 11 (9.7%) | 2 (1.4%) | 0 (0%) | 0.0012 |
| 30 day mortality | 1 (0.9%) | 4 (2.8%) | 3 (1.5%) | 0.5 |
| 1 year mortality | 4 (3.5%) | 6 (4.1%) | 4 (2.1%) | 0.52 |
| 30 day repeat MI | 5 (4.4%) | 8 (5.5%) | 5 (2.6%) | 0.38 |
| 1 year repeat MI | 5 (4.4%) | 4 (2.8%) | 5 (2.6%) | 0.18 |
| In-hospital CABG | 5 (4.4%) | 2 (1.4%) | 3 (1.5%) | 0.18 |
| 30 day revascularization | 7 (6.2%) | 6 (4.1%) | 13 (6.7%) | 0.59 |
| 1 year revascularization | 11 (9.7%) | 20 (14%) | 23 (12%) | 0.61 |
| 30 day CHF | 1 (0.9%) | 2 (1.4%) | 4 (2.1%) | 0.71 |
| 1 year CHF | 4 (3.5%) | 4 (2.8%) | 1 (0.5%) | 0.14 |
CTO cases requiring GuideLiner support.
| Variable | n= 63 |
|---|---|
| Age (years) | 68 (60–75) |
| Male gender | 49, 78% |
| BMI (kg/m2) | 30 (27, 34) |
| Medical history | |
| Hypertension | 47 (75%) |
| Dyslipidemia | 47 (75%) |
| Stroke | 7 (11%) |
| Diabetes | 20 (32%) |
| Smoking | 22 (14%) |
| PVD | 6 (9.5%) |
| CKD | 3 (4.8%) |
| CHF | 4 (6.3%) |
| Prev MI | 34 (54%) |
| Prev PCI | 34 (54%) |
| Prev CABG | 10 (16%) |
| Creatinine (µmol/L) | 106.5 (85, 127) |
| Syntax | 19 (12, 24) |
| Access | |
| Femoral | 19 (30%) |
| Radial | 18 (29%) |
| Both | 26 (41%) |
| Fluoroscopy time, (min) | 56 (39, 77) |
| Total contrast (mL) | 250 (190, 300) |
| GuideLiner used for | |
| Left main | 1 (2%) |
| LAD | 4 (6%) |
| Circumflex | 2 (3%) |
| RCA | 56 (89%) |
| Lesion length (mm) | 11 (10, 20) |
| Bifurcation or trifurcation | 4 (6%) |
| Proximal lesion | 31 (49%) |
| Extreme tortuosity | 11 (17%) |
| Severe calcification | 17 (27%) |
| Thrombus | 1 (2%) |
| Anomalous takeoff | 4 (6%) |
| Type C lesion | 63 (100%) |
| Successful delivery | 56 (89%) |
| Final TIMI grade 3 | 49 (78%) |